Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers

Area of Science:

• Oncology
• Radiology
• Pathology

Background:

• Neuroendocrine neoplasms (NENs) represent a heterogeneous tumor group with rising incidence.
• Increased awareness, diagnostic capabilities, and an aging population contribute to this trend.
• The 2019 World Health Organization classification highlights the need for combined radiologic and histopathologic assessment.

Purpose of the Study:

• To review current developments and challenges in the imaging, diagnosis, and management of NENs.
• To emphasize the importance of integrated diagnostic approaches for personalized treatment planning.

Main Methods:

• Review of current literature on NEN imaging, diagnosis, and treatment.
• Discussion of the roles of CT, MRI, and PET/CT in NEN management.
• Analysis of challenges and pitfalls in NEN imaging interpretation.

Main Results:

• Imaging plays a critical role in NEN detection, staging, treatment planning, and monitoring.
• Various imaging modalities (CT, MRI, PET/CT) have distinct advantages and limitations.
• Personalized treatment strategies are based on tumor characteristics, stage, and patient factors.

Conclusions:

• Accurate NEN diagnosis and management necessitate a multidisciplinary approach integrating imaging and histopathology.
• Ongoing advancements in imaging and therapeutics are crucial for improving patient outcomes.
• Addressing interpretative challenges in NEN imaging is essential for effective clinical decision-making.